MCRR Refugees Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : MCRR Refugees

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: out_of_the_loop who wrote (66)	7/6/1998 4:29:00 PM
From: Graham Marshman	Read Replies (1) of 582

Hi, This is the simple statement of what they're working on taken from their web site. To the best of my knowledge, splicing of single strand DNA has not been previously achieved without subsequent cell death. Graham -----------> CYGS is an emerging bioscience Research and Development company. The primary focus in 1996 -1997 has been cellular biology and genetics with particular emphasis on telomeres. In April '97, CSI acquired the rights to a patented vector that can create a single strand of DNA in the body (in vivo) to repair telomeres shortened during cell division (mitosis) in all eukariotic cells. The research is in the pre-clinical laboratory phase. This "Processive Elongation of Telomeric Repeats" (PETR) protocol promises significant applications in anti-aging (geriatrics) and cancer (oncology) therapies.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next